Format

Send to

Choose Destination
Haematologica. 2019 Apr 19. pii: haematol.2019.219253. doi: 10.3324/haematol.2019.219253. [Epub ahead of print]

Molecular remissions are observed in chronic adult T cell leukemia/lymphoma in patients treated with mogamulizumab.

Author information

1
Dept. of Medicine and Dept. of Haematology, Imperial College NHS Trust, London, UK.
2
Skin Tumour Unit, Guys Hospital, Great Maze Pond, London, UK.
3
Section of Virology, Department of Medicine, Imperial College London, UK.
4
Department of Haematology, Guys Hospital, Great Maze Pond, London.
5
National Centre for Human Retrovirology, Imperial College NHS Trust, St Mary Hospital, London, UK.
6
Department of Haematology, Imperial College NHS Trust, Hammersmith Hospital, London, UK.
7
Department of Haematology, Guys Hospital, Great Maze Pond, London, UK.
8
Department of Medicine, Imperial College, St Mary Hospital, London, UK.
9
Section of Virology, Department of Medicine, Imperial College London a.rowan@imperial.ac.uk.

KEYWORDS:

Adult T cell leukemia/lymphoma; Human T lymphotropic virus type 1; Minimal Residual Disease; Mogamulizumab

PMID:
31004017
DOI:
10.3324/haematol.2019.219253
Free full text

Supplemental Content

Full text links

Icon for HighWire
Loading ...
Support Center